首页 >
法规速递
-
Cross Labeling Oncology Drugs in Combination Regimens (Final)-2022/11/2
2022-11-30查看详情 > -
Regulatory and procedural guideline: Good practices for industry for the prevention of human medicinal product shortages-2023/5/17
2023-05-18查看详情 > -
国家药监局关于修订二十五味珊瑚制剂药品说明书的公告（2023年第144号）-2023/11/22
2023-11-23查看详情 > -
国家药监局综合司关于做好有关改革试点经验推广落实工作的通知-2025/1/16
2025-01-17查看详情 > -
Document: Substances considered as not falling within the scope of Regulation (EC) No. 470/2009, with regard to residues of veterinary medicinal products in foodstuffs of animal origin-2025/2/21
2025-02-24查看详情 > -
Page: Development of a guideline on the quality aspects of mRNA vaccines - Scientific guideline-2025/3/31
2025-04-01查看详情 > -
国家药监局关于将牙膏中过硬颗粒的检验方法等7项方法纳入化妆品安全技术规范（2015年版）的通告（2025年第18号）-2025/5/7
2025-05-08查看详情 > -
Document: Agenda - PDCO agenda of the 17-20 June 2025 meeting-2025/6/17
2025-06-18查看详情 > -
Page: Requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD) - Scientific guideline-2025/7/21
2025-07-22查看详情 > -
关于公开征求ICH《E20：临床试验的适应性设计》指导原则草案意见的通知-2025/9/8
2025-09-09查看详情 >
